Clinical Association of Negative Lymph Nodes With Adjuvant Chemotherapy in Patients With T3N0 Rectal Cancer
Conclusion: NLN count is an independent prognostic factor in patients with T3N0 rectal cancer. Patients with low NLN counts (NLN < 21) may benefit from adjuvant chemotherapy.
Saved in:
| Main Authors: | Dongxu Lei, Zhanzhen Liu, Xinyi Kang, Ziwei Zeng, Hao Xie, Tanxing Cai, Fujin Ye, Li Xiong, Wenxin Li, Zhenxing Liang, Xiaobin Zheng, Shuangling Luo, Huashan Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/grp/3241615 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimal number of lymph nodes for long-term survival in lymph node-negative rectal cancer: a population-based study
by: Lei Liu, et al.
Published: (2025-08-01) -
MESENTERIC LYMPH NODES IN SIMULATED RECTAL CANCER UNDER CONDITIONS OF CHEMOTHERAPY
by: N. B. Isakova, et al.
Published: (2016-02-01) -
Inadequate Lymph Node Yield: An Inadequate Indication for Adjuvant Chemotherapy in Stage II Colon Cancer
by: Alan Zambeli-Ljepović, MD, MHS, et al.
Published: (2023-12-01) -
Post-chemoradiotherapy adjuvant chemotherapy of rectal cancer
by: E. V. Ledin, et al.
Published: (2018-08-01) -
Upfront surgery, neoadjuvant chemoradiotherapy, or neoadjuvant chemotherapy for rectal cancer with lateral lymph node metastasis: A multicenter MRI and lateral lymph node dissection study
by: Takuya Miura, et al.
Published: (2025-03-01)